A year after President Donald Trump was sworn in for a second term, his approval rating remains at around 45%, according to Morning Consult’s weekly polling—though voters’ views of his handling of ...
Jan. 22, 2026 Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of the disease. An experimental antibody targets a protein that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results